View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Florence Healthcare Wins DPharm Idol 2016


  • September 21, 2016

  • Congratulations to Florence Healthcare, this year’s DPharm Idol winner!

    fullsizerender

    Florence was founded by Andres Garcia (CTO), Mike Kassin, MD (CMO), and Ryan Jones (CEO), — who previously held positions at Microsoft SharePoint, Pubget and BCG. The company name echoes Florence Nightengale, the mother of modern nursing, and embodies the ideals of empathy, reliability and consistency. Core users of the solution are site-based research nurses and coordinators.

    Florence offers the eBinder Suite, a software-as-a-service (SaaS) platform that is designed to simplify clinical trial document management at the trial site. The eBinder Suite enables clinical trial sites to store and manage paper files in the cloud, and automates some of the most time-consuming manual processes for both the site and the pharmaceutical sponsor.

    eBinders ultimately ensures clinical teams are able to spend more time helping patients and less time dealing with paperwork. Meanwhile, it speeds study time by enabling remote sponsor access for monitoring and queries.

    “The opportunity for long-term archiving in a digital format is really, really appealing,” said DPharm Idol judge Julian Jenkins, PhD. “eBinders are a real difference-maker.”

    Furthermore, Florence recently received seed funding, and Jones pointed out that Florence has grown at a rate of 80% month to month over the past year thanks in part to the success of eBinders.

    DPharm Idol encourages participating companies to showcase what they believe to be a disruptive clinical trial service or technology. Each DPharm Idol participant receives only a few minutes to highlight its clinical trial service or technology, followed by a brief Q&A session with a panel of judges.

    This year’s DPharm Idol judges included:

    Laura Galuchie
    Head, Clinical Performance, Analysis & Innovation, Merck Research Laboratories 

    Julian Jenkins, PhD
    VP, Innovation Performance & Technology, GSK

    Andreas Koester, MD, PhD
    VP, Innovation R&D Operations, Janssen

    Sarah Krüg
    CEO, Cancer 101 and President, Society of Participatory Medicine

    Stephanie Petrone
    Executive Director, Medical Operations, Novartis Oncology

    Chandra Ramanathan, PhD, MBA
    VP and Head, East Coast Innovation Center, Bayer HealthCare

    Jane Rhodes, MBA, PhD
    Senior Director of New Initiatives, Biogen Idec

    Darshan Shah
    Director Global Products, Global Medicines Director, AstraZeneca

    Katherine Vandebelt
    Global Head, Clinical Innovation, Eli Lilly & Company

    Which company will follow in Florence’s footsteps to become the next DPharm Idol? Check out next year’s DPharm Idol to discover new innovations in clinical trials and find out which company will be crowned the next DPharm Idol.